Press Releases
United Becomes First US Carrier to Approve CSafe RAP Temperature-Controlled Container
United Cargo announced it will enhance its TempControl service and expand the options it offers shippers of pharmaceuticals and other life science products by...
News
LANXESS India bags two awards for its Sustainable practices and CSR initiatives
LANXESS India Private Limited, the leading specialty chemicals company has been acknowledged for its diligent adherence towards sustainable practices and concerted efforts in the...
Industry Reports
CPhI Annual report forecasts CMOs to benefit from double digit approvals for ADCs in the next 3-years
The global ADC therapeutics market is expected to grow to $4bn by 2023, with double digit approvals within 3-years, according to a new analysis...
Press Releases
Aptar Pharma QuickStart, an injectable device development kit, to launch at CPhI Worldwide
Aptar Pharma, a leading provider of innovative drug delivery systems, in combination with Schott Glass and EMA Pharmaceuticals, has announced that it will launch...
Press Releases
Apceth to Manufacture First Potential One-Time Gene Therapy for Transfusion-Dependent ฮeta-Thalassemia
apceth Biopharma GmbH, a leading company for the development and manufacturing of cell and gene therapeutics, congratulates its partner bluebird bio on the acceptance...
Press Releases
MetPยฎ Pharma Introduces Nascumยฎ-Plus Against the Onset of Air Pollution-induced Inflammation
MetPยฎ Pharma, focusing on the nasal delivery of drugs to the systemic circulation and especially to the brain, presents its Nascumยฎ-Plus nasal gel. ...
Press Releases
Orchard Therapeutics Receives EMA PRIME Designation for OTL-300, an Investigational Lentiviral Gene Therapy for the Treatment of Transfusion-Dependent Beta-Thalassemia
Orchard Therapeutics, a leading commercial-stage biotech company dedicated to transforming the lives of patients with rare diseases through innovative gene therapies, announced that the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from up to 5 devices at once
Must read